PatientsVille.com Logo

DECREASED APPETITE and ACTIQ

PatientsVille

DECREASED APPETITE Symptoms and Causes

Pulmonary hypertension (PH) is high blood pressure in the arteries to your lungs. It is a serious condition. If you have it, the blood vessels that carry blood from your heart to your lungs become hard and narrow. Your heart has to work harder to pump the blood through. Over time, your heart weakens and cannot do its job and you can develop heart failure.

Symptoms of PH include

  • Shortness of breath during routine activity, such as climbing two flights of stairs
  • Tiredness
  • Chest pain
  • A racing heartbeat
  • Pain on the upper right side of the abdomen
  • Decreased appetite

As PH worsens, you may find it hard to do any physical activities.

There are two main kinds of PH. One runs in families or appears for no known reason. The other kind is related to another condition, usually heart or lung disease.

There is no cure for PH. Treatments can control symptoms. They involve treating the heart or lung disease, medicines, oxygen, and sometimes lung transplantation.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for DECREASED APPETITE

DECREASED APPETITE treatment research studies

ACTIQ clinical trials, surveys and public health registries


Find Drug Side Effect reports



ACTIQ Side Effects

Somnolence (67)
Off Label Use (59)
Dental Caries (55)
Pain (44)
Vomiting (33)
Lethargy (33)
Overdose (30)
Nausea (29)
Death (29)
Tooth Loss (25)
Suicide Attempt (22)
Loss Of Consciousness (20)
Confusional State (20)
Tooth Disorder (19)
Fatigue (18)
Dependence (17)
Coma (16)
Accidental Overdose (16)
Convulsion (16)
Dyspnoea (16)
Incorrect Dose Administered (15)
Depression (14)
Hypotension (14)
Fall (13)
Diarrhoea (13)
Dehydration (13)
Withdrawal Syndrome (12)
Accidental Exposure (12)
Tachycardia (12)
Cardiac Arrest (12)
Weight Decreased (12)
Suicidal Ideation (11)
Hallucination (10)
Dry Mouth (10)
Insomnia (9)
Malignant Neoplasm Progression (9)
Pneumonia (9)
Respiratory Arrest (9)
Miosis (9)
Amnesia (9)
Anxiety (9)
Abnormal Behaviour (9)
Dysarthria (9)
Agitation (9)
Respiratory Depression (8)
Mental Status Changes (8)
Treatment Noncompliance (8)
Hyperhidrosis (8)
Malaise (8)
Tremor (8)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

1st day was hell, had about every side effect in the book. 2nd day was better, side effects decreased greatly 5th day is going well so far- feeling a little 'edgy & apprehensive' but better than the alternative

40mg per dose 3 days a week Nausea and tiredness and fatigue and loss of appetite 30 mg - doing better But has anyone else experienced a sore tender neck with radiating sore ear jaw and headache

Afater taking glifage for 5 months, stopped because of complete lack of appetite and taste, loss of 20 lbs. and thinking process affected.

After 1 day I developed sevre flu-like body aches and total loss of appetite. It was 4 days before I remembered to read the side effect fact sheet and realized what this drug was putting me through. I had shortness of breath wnen I tried to

After a few weeks on Piascledine, knee and back pain decreased considerably with no side effects noted. Not perfect, but much better. I was walking like an old man.

After a nasty experience with citalapram i was advised by my doc to try mirtazapine and it has suitedme very well. only side effect i canreport is an appetite increase. However as i don't carry much weight that isnt a problem.&

After dealing with nausea for days, total lack of appetite I then started with a temp.of 101.5 and it went up to 103. That lasted for 3 days ( my sinuss infection at this point was cleard up, so I stopped taking the meds. NOW, I am experiencing very

After having stilnoct for atleast 6 months, there is occuring of head heaviness,fever, dry mouth,constipation, lack of appetite.

Age 79, sciatic, pain relief with 2 to 3 per day. slight loss of appetite

Am on Klacid, two tablets daily. Experiencing increase in heart rate, Chest pains, Bitter taste in the mouth day and night; also everything tastes bitter, Lack of appetite, stomach ache, abdominal pains,stomach bloated; tired yet anxious. Sleepless n

DECREASED APPETITE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Procedural Pain Treatment With Transmucosal Sublingual Fentanyl Tablet in Colonoscopy Patients
Conditions: Colonoscopy;   Pain
Interventions: Drug: Fentanyl;   Drug: Placebo
Outcome Measures: Efficacy of fentanyl transmucosal tablet to placebo in patients having colonoscopy.;   The safety of fentanyl transmucosal tablet to placebo in patients having colonoscopy.
2 Recruiting Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain
Conditions: Chronic Pain;   Sternotomy;   Remifentanil;   Fentanyl
Interventions: Drug: Fentanyl;   Drug: Remifentanil
Outcome Measures: Chronic thoracic pain;   Mean Numerical Rating Scale (NRS) score;   Quality of life;   Thermal detection and pain thresholds;   Pain variability;   Use of analgesics during and after hospitalization;   Genetic variances;   Total medical costs and productivity costs during one year, including costs of hospitalization days (ICU and non-ICU) and costs of medications;   Mean pain NRS (Numerical Rating Scale)
3 Not yet recruiting Study to Explore Effectiveness of Sublingual Fentanyl Spray in Emergency Department Patients With Acute Pain
Condition: Acute Pain
Interventions: Drug: Morphine 6 mg;   Drug: Fentanyl 100 µg;   Drug: Fentanyl 200 µg;   Drug: Fentanyl 400 µg;   Drug: Placebo Sublingual Spray;   Drug: Intravenous Placebo
Outcome Measures: Percentage of participants requiring additional doses of randomized pain medication;   Percentage of participants requiring additional doses of randomized pain medication at secondary time points;   Visual analogue scale (VAS) Summed Pain Intensity Difference (SPID) calculated as Area under the Curve (AUC) every 30 minutes;   Number of Investigational Product (IP) administrations;   Time to onset of pain relief (in minutes) using the stopwatch method;   Richmond Agitation Sedation Scale (RASS) score;   Percentage of Participants requiring rescue medication;   Time until rescue medication was required;   Percentage of participants experiencing a treatment-related adverse event;   Percentage of participants with clinically significant changes in vital signs
4 Not yet recruiting Comparison of Epidural Fentanyl and Clonidine for Breakthrough Pain
Condition: Labor Pain
Interventions: Drug: Clonidine or Fentanyl;   Drug: Clonidine or fentanyl
Outcome Measures: Pain Score on a VAS scale;   Maternal blood pressure;   Maternal heart rate;   Neonatal Apgar score;   Number of spontaneous vaginal deliveries
5 Unknown  Intranasal Fentanyl for Pain Management
Conditions: Trauma;   Pain
Interventions: Drug: intravenous fentanyl;   Drug: intra-nasal fentanyl
Outcome Measures: The primary measure will be the change recorded in patients subjective pain using a standardized scale;   Change in patients vital signs: blood pressure, respiratory rate, heart rate, pulse oximetry will be monitored at 5 and 10 minutes following Atomized Fentanyl
6 Recruiting Intranasal Fentanyl for Management of Pain Associated With Cystoscopic Procedures
Conditions: Other Acute Pain;   Pain Experienced During Cystoscopy
Intervention: Drug: Fentanyl pectin
Outcome Measures: Change from baseline in pain numeric rating scale;   Oxyhemoglobin saturation
7 Recruiting Safety and Efficacy Study of Fentanyl Buccal Tablet Use in the Emergency Department for Isolated Extremity Injury
Condition: Pain
Interventions: Drug: Fentanyl;   Drug: Oxycodone/acetaminophen;   Drug: oxycodone/acetaminophen
Outcome Measures: Pain Level;   Nausea level;   Occurrence of adverse events
8 Recruiting Fentanyl for Breakthrough Pain in the Emergency Department
Condition: Pain
Interventions: Drug: Fentanyl Nasal Spray;   Drug: Hydromorphone PCA;   Other: Placebo Nasal Spray
Outcome Measure: Total Pain Relief Score
9 Unknown  Epidural Volume Extension and Intrathecal Use of Local Anesthetics in Cesarean Sections
Condition: Stillborn Caesarean Section
Interventions: Drug: Bupivacaine- Fentanyl - Normal Saline;   Drug: Ropivacaine-Fentanyl-Normal Saline;   Drug: Levobupivacaine- Fentanyl- Normal Saline;   Drug: Bupivacaine + Fentanyl;   Drug: Ropivacaine + Fentanyl;   Drug: Levobupivacaine + Fentanyl
Outcome Measures: Dermatomes of Sensory block;   Motor block;   Arterial Blood Pressure
10 Unknown  Safety of Fentanyl TAIFUN Treatment
Condition: Breakthrough Cancer Pain
Interventions: Drug: Fentanyl TAIFUN;   Drug: Opioid
Outcome Measures: AE Profile;   To characterize the safety of Fentanyl TAIFUN treatment vs. the current BTP treatment based on the AE profile;   To estimate the proportion of patients taht can be titrated to an effective dose of Fentanyl TAIFUN;   To evaluate the efficacy of Fentanyl TAIFUN with the titrated dose and the current BTP treatment with the confirmed dose;   To evaluate patients's preference between Fentanyl TAIFUN and the baseline BTP medication;   To evaluate the sustained analgesic effect of Fentanyl TAIFUN and the current BTP treatment
11 Not yet recruiting An Assessment of the Ability of Fentanyl Citrate Nasal Spray to Manage Breakthrough Pain in Cancer Patients.
Condition: Pain
Intervention: Drug: Fentanyl Citrate Nasal Spray (FCNS)
Outcome Measures: Pain Intensity;   Pain Management Satisfaction
12 Not yet recruiting Effectiveness of Intranasal Versus Intravenous Fentanyl in Preterm and Term Newborns for Pain Prevention
Condition: Pain
Intervention: Drug: Fentanyl
Outcome Measure: Pain scale - N-PASS
13 Recruiting Compare Propofol to Fentanyl and Midazolam for Colonoscopy
Conditions: Colon Cancer;   Rectal Cancer;   Colonic Diverticulosis
Interventions: Drug: Fentanyl;   Drug: Propofol;   Drug: Midazolam
Outcome Measures: Patient satisfaction;   Patient discomfort
14 Recruiting Fentanyl Pectin Nasal Spray (FNPS) for Exercise-Induced Breakthrough Dyspnea
Condition: Advanced Cancers
Interventions: Drug: Fentanyl Pectin Nasal Spray;   Drug: Placebo Nasal Spray;   Other: Walk Test;   Behavioral: Questionnaires;   Behavioral: Mental Ability Tests
Outcome Measure: Effect of Prophylactic Fentanyl Pectin Nasal Spray (FPNS)
15 Recruiting Fentanyl in Colonoscopy
Condition: Pain
Interventions: Drug: Routine medication arm;   Drug: Fentanyl on-demand arm
Outcome Measures: Pain;   Additional medication
16 Recruiting The Value of Adding Either Meperdine or Fentanyl to Clonidine-bupivacaine
Condition: Amputation Stumps
Interventions: Drug: Meperdine;   Drug: Fentanyl
Outcome Measures: the hemodynamic effects .;   the analgesic efficacy.
17 Unknown  Subarachnoid Administration of Levobupivacaine for Cesarean Section
Condition: Stillborn Caesarean Section
Interventions: Drug: Bupivacaine plain;   Drug: Ropivacaine plain;   Drug: Levobupivacaine plain;   Drug: bupivacaine plain +fentanyl;   Drug: ropivacaine plain +. fentanyl;   Drug: Levobupivacaine plain +fentanyl
Outcome Measures: Sensory block;   Motor block;   Hemodynamics profile (arterial pressure. heart rate)
18 Recruiting Treatment of Pain in Head-and-Neck Cancer Patients: is Methadone More Effective?
Conditions: Pain;   Cancer of Head and Neck
Interventions: Drug: fentanyl;   Drug: methadone
Outcome Measures: significant pain relief (reduction of Numeric Rating Scale (NRS) of 50%);   time to achieve significant pain relief;   side-effect profile
19 Recruiting Comparison of Propofol-fentanyl and Midazolam-fentanyl for Conscious Sedation
Condition: Emergencies
Interventions: Drug: Propofol;   Drug: Midazolam;   Drug: Fentanyl
Outcome Measures: Recovery time;   Patients' Pain perception
20 Unknown  Epidural Morphine Versus Epidural Fentanyl Infusion Following Cesarean Section
Condition: Pain
Interventions: Drug: Preservative free morphine;   Drug: Fentanyl
Outcome Measures: Postsurgical pain;   Nausea